Eli Lilly CEO says Medicare coverage of obesity drugs could ‘change the game’ for upcoming pill launch
Eli Lilly CEO Dave Ricks on Friday said upcoming Medicare coverage of obesity drugs could be a major catalyst for ...
Tag: Biotechnology
What obesity drugmakers see next in the market: More pills, easier access and drug combinations
A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, Jan. 15, 2026.George Frey | Bloomberg ...
Novo Nordisk shares rise 8% after Wegovy obesity pill has ‘solid’ launch
A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, Jan. 15, 2026.George Frey | Bloomberg ...
Inside the dealmaking that pushed Trump to reclassify pot, expand access
President Donald Trump's move Thursday to sign an executive order easing federal restrictions on marijuana — and clearing the way ...
Eli Lilly to build $6 billion manufacturing plant in Alabama to help make upcoming obesity pill, other drugs
Eli Lilly CEO David A. Ricks speaks at a press conference at Generation Park in Houston, Monday, Sept. 23, 2025. ...
‘Terrifying’: Why U.S. senator in top intel post wants more spying on Chinese companies
Go back a decade and most Americans had never heard of Huawei. Today, the Chinese telecom giant is a symbol ...
Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site
Eli Lilly on Monday said it is lowering the cash prices of single-dose vials of its blockbuster weight loss drug ...
Millions more Americans could access obesity drugs after Trump’s deals with Eli Lilly, Novo Nordisk
US President Donald Trump makes an announcement in the Oval Office of the White House in Washington, DC on Nov. ...
Where the blockbuster weight loss drug market stands today — and what’s coming next
A combination image shows an injection pen of Zepbound, Eli Lilly's weight loss drug, and boxes of Wegovy, made by ...
CVS beats estimates, hikes guidance as insurance business improves
Signage for a CVS pharmacy in Takoma Park, Maryland, US, on Wednesday, July 9, 2025. Al Drago | Bloomberg | ...
